WINDLAS BIOTECH share price has zoomed 6% and is presently trading at Rs 990.9.
Meanwhile, the BSE HEALTHCARE index is at 43,003.5 (down 1.0%).
Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 2.7%) and MAX HEALTHCARE INSTITUTE (up 2.0%).
Glenmark Pharma (down 3.5%) and Dr. Reddys (down 3.2%) are among the top losers today.
Over the last one year, WINDLAS BIOTECH has moved up from Rs 322.1 to Rs 990.9, registering a gain of Rs 668.8 (up 207.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,318.2 to 43,003.5, registering a gain of 57.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 225.9%), Glenmark Pharma (up 120.2%) and SUVEN PHARMACEUTICALS (up 118.7%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,897.7 (down 0.1%).
The top losers among the BSE Sensex today are Tata Motors (down 3.7%) and Maruti Suzuki (down 2.0%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.
In the meantime, NSE Nifty is at 24,287.7 (down 0.2%). Tata Motors and IOC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,049.1 to 79,897.7, registering a gain of 15,848.6 points (up 24.7%).
WINDLAS BIOTECH net profit grew 11.7% YoY to Rs 135 million for the quarter ended June 2024, compared to a profit of Rs 121 million a year ago. Net sales rose 21.0% to Rs 1,752 million during the period as against Rs 1,448 million in April-June 2023.
For the year ended March 2024, WINDLAS BIOTECH reported 36.5% increase in net profit to Rs 582 million compared to net profit of Rs 426 million during FY23. Revenue of the company grew 23.0% to Rs 6,310 million during FY24.
The current Price to earnings ratio of WINDLAS BIOTECH, based on rolling 12 month earnings, stands at 34.7.
Equitymaster requests your view! Post a comment on "WINDLAS BIOTECH Gains 6%; BSE HEALTHCARE Index Down 1.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!